全球即時診斷市場規模、佔有率、趨勢和成長分析報告（2026-2034）

預計到 2034 年，即時診斷市場規模將從 2025 年的 497 億美元成長至 825.5 億美元，2026 年至 2034 年的複合年成長率為 5.8%。

由於對快速、分散式檢測解決方案的需求不斷成長，全球照護現場診斷市場正經歷顯著成長。照護現場設備可在患者所在位置或附近提供即時診斷結果，從而改善治療決策並縮短住院時間。感染疾病、糖尿病和心血管疾病的日益普及推動了對攜帶式診斷工具的需求。

關鍵成長要素包括微型化和生物感測器技術的進步。急診室、居家醫療機構和社區診所的廣泛應用也推動了市場成長。新冠疫情加速了全球對快速檢測解決方案的認知和應用。政府為促進醫療保健服務的可近性而採取的措施也促進了市場成長。

展望未來，分子診斷技術和智慧型手機互聯檢測設備的創新將拓展其應用領域。個人化醫療和預防醫學的發展將持續支持市場需求。新興市場對醫療基礎建設的投資也蘊藏著巨大的機會。隨著醫療保健向便捷快速診斷的方向發展，照護現場仍將是現代臨床醫學的核心。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球即時診斷市場：依產品分類

• 市場分析、洞察與預測
• 血糖監測
• 傳染病檢查
• 心血管代謝疾病檢測
• 妊娠和不孕症檢查
• 驗血
• 其他

第5章 全球即時診斷市場：依檢體分類

• 市場分析、洞察與預測
• 血
• 鼻拭子和口咽拭子
• 尿
• 其他

第6章 全球即時診斷市場：依最終用戶分類

• 市場分析、洞察與預測
• 醫院床邊
• 診所內的醫生檢查室
• 急診診所和零售診所
• 家庭使用/自測

第7章 全球即時診斷市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • F. Hoffmann-La Roche Ltd
  • Abbott
  • EKF Diagnostics Holdings Plc
  • Cardinal HealthInc
  • Thermo Fisher Scientific Inc
  • Quest Diagnostics Incorporated
  • BD
  • BioMerieux SA
  • QuidelOrtho Corporation
  • Bio-Rad Laboratories Inc

The Point Of Care Diagnostics Market size is expected to reach USD 82.55 Billion in 2034 from USD 49.70 Billion (2025) growing at a CAGR of 5.8% during 2026-2034.

The Global Point of Care Diagnostics Market has experienced substantial growth due to increasing demand for rapid and decentralized testing solutions. Point-of-care devices enable immediate diagnostic results at or near the patient site, improving treatment decisions and reducing hospital stays. Rising prevalence of infectious diseases, diabetes, and cardiovascular conditions has fueled demand for portable diagnostic tools.

Major growth drivers include technological advancements in miniaturization and biosensor technologies. Increasing adoption in emergency rooms, home healthcare settings, and rural clinics supports market expansion. The pandemic accelerated awareness and deployment of rapid testing solutions globally. Government initiatives promoting accessible healthcare services further contribute to growth.

Looking forward, innovation in molecular diagnostics and smartphone-integrated testing devices will expand application areas. Growth in personalized medicine and preventive healthcare will sustain demand. Emerging economies investing in healthcare infrastructure provide strong opportunities. As healthcare shifts toward convenience and faster diagnosis, point-of-care diagnostics will remain central to modern clinical practices.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Blood Glucose Monitoring
• Infectious Disease Testing
• Cardiometabolic Disease Testing
• Pregnancy & Fertility Testing
• Hematology Testing
• Others

By Sample

• Blood
• Nasal and Oropharyngeal Swabs
• Urine
• Others

By End-User

• Hospital Bedside
• Physician's Office Lab
• Urgent Care & Retail Clinics
• Home & Self testing

COMPANIES PROFILED

• F HoffmannLa Roche Ltd, Abbott, EKF Diagnostics Holdings plc, Cardinal Health, Inc, Thermo Fisher Scientific Inc, Quest Diagnostics Incorporated, BD, bioMerieux SA, QuidelOrtho Corporation, BioRad Laboratories Inc

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL POINT OF CARE DIAGNOSTICS MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Blood Glucose Monitoring Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Infectious Disease Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Cardiometabolic Disease Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Pregnancy & Fertility Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Hematology Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL POINT OF CARE DIAGNOSTICS MARKET: BY SAMPLE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Sample
• 5.2. Blood Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Nasal and Oropharyngeal Swabs Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Urine Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL POINT OF CARE DIAGNOSTICS MARKET: BY END-USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-user
• 6.2. Hospital Bedside Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Physician's Office Lab Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Urgent Care & Retail Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Home & Self testing Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL POINT OF CARE DIAGNOSTICS MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product
  • 7.2.2 By Sample
  • 7.2.3 By End-user
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product
  • 7.3.2 By Sample
  • 7.3.3 By End-user
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product
  • 7.4.2 By Sample
  • 7.4.3 By End-user
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product
  • 7.5.2 By Sample
  • 7.5.3 By End-user
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product
  • 7.6.2 By Sample
  • 7.6.3 By End-user
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL POINT OF CARE DIAGNOSTICS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 F. Hoffmann-La Roche Ltd
  • 9.2.2 Abbott
  • 9.2.3 EKF Diagnostics Holdings Plc
  • 9.2.4 Cardinal HealthInc
  • 9.2.5 Thermo Fisher Scientific Inc
  • 9.2.6 Quest Diagnostics Incorporated
  • 9.2.7 BD
  • 9.2.8 BioMerieux SA
  • 9.2.9 QuidelOrtho Corporation
  • 9.2.10 Bio-Rad Laboratories Inc